Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising
By Ernie Mundell HealthDay Reporter
THURSDAY, Oct. 31, 2024 -- A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 2021 that same patient spent $2,378 annually, a new report finds.
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University in Columbus.
“In some cases, the out-of-pocket cost to patients has increased much more than the total cost of the drug, indicating that patients are taking on a disproportionate amount of the burden of these cost increases,” Gurovsky noted. Her team published its findings Oct. 30 in the journal Neurology.
They pored over data from a large private health care claims database, looking for changes in the cost to patients of meds for five different neurological conditions from 2012 through 2021.
In total, they looked at data for about 186,000 people with epilepsy, 169,000 with peripheral neuropathy, nearly 61,000 with Alzheimer’s or other dementia, close to 55,000 with MS and about 46,000 with Parkinson’s disease.
MS patients faced the sharpest upticks in out-of-pocket costs, more than tripling over the nine years of the study.
“MS medications costs remain exceptionally high and pose a substantial financial burden to people with this devastating disease,” Gusovsky said in a journal news release. “It’s imperative that we develop policy solutions such as caps on costs, value-based pricing and encouraging production of generic drugs to address this issue.”
Generics could make a difference: The study found that when new generics emerged on the market, that could cut the cost of some drugs by 48% to 80% within a year.
Still, high deductibles and co-pays meant those savings didn't always reach patients, Gusovsky said.
In many cases "where generic drugs were introduced and the overall costs went down, the out-of-pocket costs to patients did not decrease, so they were not benefiting from these reductions," she noted.
The hit to patients' wallets can have a direct impact on their care and their health, the researchers warned. Many studies have shown that as prices rise, patients can start skipping meds, foregoing groceries or other essentials and incurring the stress of medical debt.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-11-01 06:00
Read more
- Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
- 2008 to 2022 Saw Rise in Industry-Sponsored Adult Cancer Clinical Trials
- American Thoracic Society Provides Tips for Hospitals to Manage IV Fluid Supply Amid Shortage
- E. Coli Outbreak Linked to McDonald's Quarter Pounders Widens to 75 Cases in 13 States; 22 Hospitalized
- Biden Administration Uses Wartime Powers to Help Restart IV Fluid Plant in North Carolina
- ASN: Hypertension Most Common Cardiovascular Comorbidity Seen With Dialysis
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions